The fight to curb Covid-19 has created a new divide between those who have had the vaccine and those who have not. The United States, The United Kingdom and other well off countries are on their way to immunizing their entire adult population. Yet dozens of less wealthy countries have yet to receive their first dose.
This inequity is both a moral challenge and a public health crisis. “You have coverage of a hundred percent in one rich country and then, in the following day, you have importation of new variants so all your efforts become useless,” warned Eduardo Samo Gudo, Scientific Director at Mozambique’s National Institute of Health.
“From where we are in Africa,” said Emma Ingaiza who manages a clinic in the legendary Mathare slums of Nairobi, “we would want the world out there to understand that we are equally important. That our lives also matter. We’re just on the front line as much as everyone else is.”
Co-host Claudia Romo Edelman, who worked on the challenge of supply of treatment and vaccine for HIV/AIDS, Tuberculosis and Malaria, said the world saw this crisis coming. But the solution created by the World Health Organization and other groups, called COVAX, has been slow to raise the money from high income countries and then buy the vaccine supply it is committed to delivering to low income countries.
Roz Scourse of Doctors Without Borders says COVAX has failed and that the solution is plan offered by South Africa, India and many countries in the global south to waive Intellectual Property rights on the new vaccines so poor and middle countries can make their own. Others, however, worry this might undermine manufacturing quality while doing nothing to solve the problem that high income countries have bought most of the current supply.
Kristina Kloberdanz, Chief Sustainability Officer for Mastercard, sponsor of Global GoalsCast, discusses Mastercard’s work on global gender equity – for example by conducting annual salary reviews, closing the gender pay gap, instituted gender n
Emma has more than 6 years’ experience in health programs design, management and implementation with a focus on increased access to affordable and quality primary healthcare among underserved communities. She has experience in designing and implementing programs addressing disease management, maternal and child health, nutrition, HIV care, adolescent sexual and reproductive health (ASRH), and is highly skilled at building cross-cultural relationships among communities in urban informal settlements.
Emma is a clinical officer with an ongoing distance learning Bachelor of Science (BSc) degree in Health Systems Management. She is currently overseeing SHINING HOPEFOR COMMUNITIES (SHOFCO) primary healthcare services in a level 2 hospital in Mathare , Nairobi. She has had an opportunity to represent Kenya internationally as a One Young World Fellow and regionally in the Young African Leadership initiative East Africa (Yalieastafrica) Fellowship under Public management track. Through volunteer networks the power to arrest the spread of disease is moving from healthcare providers to communities.
Roz joined the MSF Access Campaign in 2016 and works on issues related to ensuring equitable access to medical products globally, including vaccines, treatments and diagnostics. Roz is based in the UK and focuses on monitoring UK policies and laws related to access, as well as following specific products being developed in the UK and advocating for strategies and policies which aim to maximise access for people living in countries where MSF works, and beyond. This includes monitoring issues related to intellectual property (IP), affordability, supply, allocation, transparency, and sharing of IP, data and knowledge.
Previous to MSF, Roz worked with civil society organisations (CSOs), researchers and campaigners on health inequities with a particular focus on access to health services and medical tools. Roz has previously worked with a number of UK-based national and international CSOs, the All-Party Parliamentary Group (APPG) on HIV/AIDS, within the NHS on HIV research programmes, as well as with marginalised communities impacted by a lack of access to health services.
Thabani Maphosa is Gavi’s Managing Director of Country Programmes, overseeing Gavi’s operations in 73 countries. The Country Programmes Department’s raison d’être is to harness the power of the Vaccine Alliance for countries to save the maximum number of lives through immunisation. This is achieved through maximising financial investments (donor and domestic), bringing the best partners to the table and driving innovative solutions. The Country Programmes Department manages Gavi’s relationships with governments and provides grant management oversight for all in-country resources.
Prior to joining Gavi, Thabani held several leadership roles in World Vision International for over 16 years. Thabani is a seasoned humanitarian who has led disaster preparedness and response efforts globally. He is also recognised for introducing the use of technology in the last mile and not least for scaling up cash transfers in stable and fragile contexts.
With a Master of Philosophy degree in Science, Thabani has worked in academia as a lecturer in physiology and microbiology.
Eduardo Samo Gudo is the Scientific Director at National Institute of Health, Ministry of Health, Mozambique, and a medical researcher in the field of Immunology and Virology.
Samo Gudo received a degree in Medicine (MD) at Eduardo Mondlane University in Mozambique in 2003, and PhD in Immuno-retrovirology at FIOCRUZ in Brazil in 2012.
Dr Siddhartha Datta, MD, MPH, is the Regional Advisor for Vaccine-preventable diseases and Immunization programme in the WHO European Region, leading a team that supports WHO Member States with routine immunization coverage as well as currently the preparation for and rollout of COVID-19 vaccines and vaccination. Dr Datta has served WHO in Papua New Guinea and Lao PDR as a Technical Lead, and earlier worked as a State Routine Immunization Officer focused on polio and routine immunization in Uttar Pradesh, India.
Kristina Kloberdanz Mastercard’s Chief Sustainability Officer. She is responsible for leading Mastercard’s approach to sustainability as defined by three key pillars: being good stewards of the environment, making positive social impact, and ensuring high standards of corporate governance. Kristina drives efforts to integrate and embed sustainability initiatives across business units and throughout the company as an accelerator of strategic growth. She joined Mastercard in May 2017 as Vice President of Corporate Sustainability, leading the development of the company’s sustainability report. Prior to that, she worked for IBM leading their global corporate responsibility/sustainability strategy, integration and brand reputation.